What is osmotic demyelination syndrome (ODS) in the setting of hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Osmotic Demyelination Syndrome (ODS) in Hyponatremia

ODS is a devastating neurological complication that occurs when chronic hyponatremia is corrected too rapidly, causing demyelination of brain tissue—particularly in the pons—resulting in potentially irreversible neurological damage including quadriparesis, dysphagia, dysarthria, and locked-in syndrome. 1

What ODS Is

ODS develops when serum sodium rises too quickly in patients with chronic hyponatremia, creating an osmotic gradient that damages myelin sheaths in the central nervous system. The prototypical course begins 2-7 days after rapid sodium correction, with patients initially presenting with seizures or encephalopathy, followed by brief improvement, then devastating clinical deterioration with dysarthria, dysphagia, oculomotor dysfunction, and quadriparesis. 1

The condition can be diagnosed through:

  • Physical examination findings showing the characteristic neurological deficits
  • Brain MRI demonstrating hyperintensities in the pons (central pontine myelinolysis) and/or extrapontine regions including basal ganglia 1

High-Risk Populations

ODS risk is substantially elevated in patients with:

  • Advanced liver disease (cirrhosis)
  • Chronic alcoholism
  • Severe hyponatremia (especially <120 mEq/L)
  • Malnutrition
  • Severe metabolic derangements (hypophosphatemia, hypokalemia, hypoglycemia)
  • Low cholesterol levels
  • Prior hepatic encephalopathy 1

Critical Prevention: Safe Correction Rates

The 2021 AASLD guidelines provide explicit correction targets based on ODS risk: 1

For High-Risk Patients (including advanced liver disease):

  • Goal: 4-6 mEq/L per 24 hours
  • Maximum: 8 mEq/L per 24 hours

For Average-Risk Patients:

  • Goal: 4-8 mEq/L per 24 hours
  • Maximum: 10-12 mEq/L per 24 hours

These limits apply to each consecutive 24-hour period, not just the initial correction. 1

Critical Distinction: Acute vs. Chronic Hyponatremia

This is where clinical judgment becomes crucial:

  • Acute hyponatremia (<48 hours onset): Can and should be corrected rapidly to prevent cerebral edema, without concern for ODS 1
  • Chronic hyponatremia: Requires gradual, measured correction to avoid ODS 1

The challenge is that chronic hyponatremia is far more common in clinical practice, particularly in cirrhosis, and the timeline is often unclear.

Management of Overcorrection

If sodium rises too rapidly, immediate intervention is warranted: 1

  • Administer electrolyte-free water to re-lower sodium
  • Consider desmopressin to prevent further sodium rise
  • Tromethamine may reduce ODS risk 1

Clinical Reality vs. Guidelines

Recent large-scale data reveals important nuances: In a multicenter study of 22,858 hospitalizations with hyponatremia, rapid correction occurred in 17.7% of cases, yet ODS developed in only 0.05% (12 patients). Notably, 58% of ODS cases occurred without rapid correction, suggesting other factors contribute to risk 2. However, this should not lead to complacency—when ODS occurs, outcomes are catastrophic.

Common Pitfalls to Avoid

  1. Intraoperative sodium loading: Large volumes of blood products, fresh frozen plasma, and saline solutions during liver transplant or other surgeries can cause inadvertent rapid correction 1

  2. Assuming all hyponatremia is chronic: In neurosurgical settings particularly, acute hyponatremia may require aggressive correction to prevent cerebral edema 3

  3. Inadequate monitoring: Sodium levels must be checked frequently (every 4-6 hours initially) during active correction to detect overcorrection early

  4. Treating the number, not the patient: Asymptomatic mild hyponatremia (126-135 mEq/L) requires only monitoring and water restriction 1

The Bottom Line

ODS is rare but devastating—prevention through controlled sodium correction is paramount, as no definitive treatment exists once demyelination occurs. 4 While recent evidence suggests overcorrection may be less dangerous than previously thought 2, 5, the catastrophic nature of ODS when it does occur mandates adherence to conservative correction rates, especially in high-risk populations. Multidisciplinary coordination is essential, particularly in liver transplant candidates where severe hyponatremia is common. 1

References

Related Questions

What are the signs and symptoms of osmotic demyelination syndrome?
In a 6-year-old female presenting with altered mental status and metabolic acidosis, which initial tests should be ordered—serum osmolarity, a urine electrolyte panel (urine sodium, chloride, and pH), or brain MRI?
A 77-year-old patient has an initial serum sodium of 130 mmol/L and a repeat level of 129 mmol/L after four weeks; what is the next step in management and appropriate treatment?
In a patient on lamotrigine (Lamictal) and lorazepam (Ativan) with mild hypotonic hyponatraemia (serum sodium 134 mEq/L, serum osmolality 274.8 mOsm/kg), should sodium replacement be performed?
What is the appropriate outpatient management for a clinically stable patient with acute hyponatremia and a serum sodium of 126 mmol/L?
What is the appropriate treatment for nummular eczema (discoid eczema)?
How should a T12 vertebral fracture be managed?
Can a patient with end-stage renal disease (CKD stage 5) be treated with the HRZE anti‑tuberculosis regimen?
What type of brace is appropriate for a T12 thoracolumbar fracture?
Why is my serum chloride level of 110 mmol/L elevated?
What BI‑RADS category and imaging work‑up are recommended for a patient with spontaneous unilateral bloody nipple discharge?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.